Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Leibniz Institute for New Materials (INM) is a prominent research center focused on the development of innovative materials at the interface of biology and chemistry. Based in Saarbrücken, Germany, the institute specializes in creating functional surfaces, antimicrobial coatings, and advanced drug delivery systems. Their research in 'Bio-interfaces' focuses on how materials interact with living cells and tissues, leading to breakthroughs in regenerative medicine and medical device technology. INM operates as a non-profit research organization, bridging the gap between fundamental science and industrial application through extensive collaborations with pharmaceutical and medical technology companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leibniz Institute for New Materials.